4-1BBT,,

Wonyoung Choi1, Youngjoo Lee2, Beom K Choi3

  • 1Center for Clinical Trials, National Cancer Center, Goyang, Republic of Korea; Center for Rare Cancers, National Cancer Center, Goyang, Republic of Korea.

Cytotherapy
|August 26, 2023
PubMed
概括

产生人类端粒酶逆转录酶特异性CD8+T细胞 (TERTiNTs) 对癌症患者来说是可行的和安全的. 这种方法在重度预先治疗的个体中显示出疾病稳定,表明抗癌治疗的潜力.